Company: PFSA
Filing Date: 2025-10-09
Form Type: S-1
Source: 0001213900-25-097860
Chunk: 316

Company: Profusa, Inc.
Filing Date: 2025-10-09
Form: S-1
Chunk 316
---
data):

|                                                                                |     | Three Months 
 Ended        
 June 30,     
 2025         |           |   |     | Three Months 
 Ended        
 June 30,     
 2024         |           |   |
|:-------------------------------------------------------------------------------|:----|:-------------|----------:|:--|:----|:-------------|----------:|:--|
| Numerator:                                                                     |     |              |           |   |     |              |           |   |
| Net loss                                                                       |     | $            |    (2,348 | ) |     | $            |    (2,071 | ) |
| Denominator:                                                                   |     |              |           |   |     |              |           |   |
| Weighted average shares used to computing basic and diluted net loss per share |     |              | 5,604,651 |   |     |              | 5,601,651 |   |
| Net loss per share attributable to common stockholders – basic and diluted:    |     | $            |     (0.42 | ) |     | $            |     (0.37 | ) |

F-49 PROFUSA, INC. AND SUBSIDIARY
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED) Note 11 — Net Loss per Share Attributable to Common Stockholders(cont.)

The following outstanding shares
of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders
for the periods presented because including them would have been antidilutive:

|                                  |     | Three months ended 
           June 30, |            |    |     |      |            |    |
|                                  |     |               2025 |            |    |     | 2024 |            |    |
| Convertible preferred stock      |     |                    | 17,863,934 |    |     |      | 17,863,934 |    |
| Convertible notes payable(1)     |     |                    | 42,430,263 |    |     |      | 25,721,548 |    |
| Convertible loans                |     |                    |          — | -2 |     |      |          — | -2 |
| Options to purchase common stock |     |                    |  4,520,250 |    |     |      |  2,972,055 |    |
|